142 related articles for article (PubMed ID: 16329659)
1. Parvovirus B19: a new emerging pathogenic agent of inflammatory cardiomyopathy.
Bock CT
Ernst Schering Res Found Workshop; 2006; (55):83-97. PubMed ID: 16329659
[TBL] [Abstract][Full Text] [Related]
2. Human parvovirus B19: a new emerging pathogen of inflammatory cardiomyopathy.
Bock CT; Klingel K; Aberle S; Duechting A; Lupescu A; Lang F; Kandolf R
J Vet Med B Infect Dis Vet Public Health; 2005; 52(7-8):340-3. PubMed ID: 16316397
[TBL] [Abstract][Full Text] [Related]
3. Frequent detection of parvovirus B19 genome in the myocardium of adult patients with idiopathic dilated cardiomyopathy.
Lotze U; Egerer R; Tresselt C; Glück B; Dannberg G; Stelzner A; Figulla HR
Med Microbiol Immunol; 2004 May; 193(2-3):75-82. PubMed ID: 14689308
[TBL] [Abstract][Full Text] [Related]
4. [Virus etiology of inflammatory cardiomyopathy].
Kandolf R
Dtsch Med Wochenschr; 2004 Oct; 129(41):2187-92. PubMed ID: 15457399
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of the parvovirus B19 genome in endomyocardial biopsy specimens.
Pankuweit S; Moll R; Baandrup U; Portig I; Hufnagel G; Maisch B
Hum Pathol; 2003 May; 34(5):497-503. PubMed ID: 12792925
[TBL] [Abstract][Full Text] [Related]
6. Analysing myocardial tissue from explanted hearts of heart transplant recipients and multi-organ donors for the presence of parvovirus B19 DNA.
Donoso Mantke O; Nitsche A; Meyer R; Klingel K; Niedrig M
J Clin Virol; 2004 Sep; 31(1):32-9. PubMed ID: 15288611
[TBL] [Abstract][Full Text] [Related]
7. Parvovirus B19: a pathogen responsible for more than hematologic disorders.
Bültmann BD; Klingel K; Sotlar K; Bock CT; Kandolf R
Virchows Arch; 2003 Jan; 442(1):8-17. PubMed ID: 12536309
[TBL] [Abstract][Full Text] [Related]
8. Parvovirus B19: the causative agent of dilated cardiomyopathy or a harmless passenger of the human myocard?
Modrow S
Ernst Schering Res Found Workshop; 2006; (55):63-82. PubMed ID: 16329658
[TBL] [Abstract][Full Text] [Related]
9. Pathophysiology and aetiological diagnosis of inflammatory myocardial diseases with a special focus on parvovirus B19.
Pankuweit S; Ruppert V; Eckhardt H; Strache D; Maisch B
J Vet Med B Infect Dis Vet Public Health; 2005; 52(7-8):344-7. PubMed ID: 16316398
[TBL] [Abstract][Full Text] [Related]
10. Molecular pathology of inflammatory cardiomyopathy.
Klingel K; Sauter M; Bock CT; Szalay G; Schnorr JJ; Kandolf R
Med Microbiol Immunol; 2004 May; 193(2-3):101-7. PubMed ID: 12920583
[TBL] [Abstract][Full Text] [Related]
11. Acute parvovirus B19 infection associated with myocarditis in an immunocompetent adult.
Lamparter S; Schoppet M; Pankuweit S; Maisch B
Hum Pathol; 2003 Jul; 34(7):725-8. PubMed ID: 12874772
[TBL] [Abstract][Full Text] [Related]
12. Viral epidemiologic shift in inflammatory heart disease: the increasing involvement of parvovirus B19 in the myocardium of pediatric cardiac transplant patients.
Breinholt JP; Moulik M; Dreyer WJ; Denfield SW; Kim JJ; Jefferies JL; Rossano JW; Gates CM; Clunie SK; Bowles KR; Kearney DL; Bowles NE; Towbin JA
J Heart Lung Transplant; 2010 Jul; 29(7):739-46. PubMed ID: 20456978
[TBL] [Abstract][Full Text] [Related]
13. Parvovirus B19 is a bystander in adult myocarditis.
Koepsell SA; Anderson DR; Radio SJ
Cardiovasc Pathol; 2012; 21(6):476-81. PubMed ID: 22425629
[TBL] [Abstract][Full Text] [Related]
14. Frequency and quantity of the parvovirus B19 genome in endomyocardial biopsies from patients with suspected myocarditis or idiopathic left ventricular dysfunction.
Klein RM; Jiang H; Niederacher D; Adams O; Du M; Horlitz M; Schley P; Marx R; Lankisch MR; Brehm MU; Strauer BE; Gabbert HE; Scheffold T; Gülker H
Z Kardiol; 2004 Apr; 93(4):300-9. PubMed ID: 15085375
[TBL] [Abstract][Full Text] [Related]
15. Fatal parvovirus B19-associated myocarditis clinically mimicking ischemic heart disease: an endothelial cell-mediated disease.
Bültmann BD; Klingel K; Sotlar K; Bock CT; Baba HA; Sauter M; Kandolf R
Hum Pathol; 2003 Jan; 34(1):92-5. PubMed ID: 12605372
[TBL] [Abstract][Full Text] [Related]
16. Focal epilepsy as a long term sequela of Parvovirus B19 encephalitis.
Palermo CI; Costanzo CM; Franchina C; Castiglione G; Giuliano L; Russo R; Conti A; Sofia V; Scalia G
J Clin Virol; 2016 Jul; 80():20-3. PubMed ID: 27130981
[TBL] [Abstract][Full Text] [Related]
17. Adaptive immune responses against parvovirus B19 in patients with myocardial disease.
Lindner J; Noutsias M; Lassner D; Wenzel J; Schultheiss HP; Kuehl U; Modrow S
J Clin Virol; 2009 Jan; 44(1):27-32. PubMed ID: 18980860
[TBL] [Abstract][Full Text] [Related]
18. Erythrovirus B19 infection in humans.
Kishore J; Kapoor A
Indian J Med Res; 2000 Nov; 112():149-64. PubMed ID: 12452123
[TBL] [Abstract][Full Text] [Related]
19. Molecular method to test if Parvovirus B19 is a new virus to the Old World.
Lewin Altschuler E
Med Hypotheses; 2004; 62(5):795-6. PubMed ID: 15082109
[TBL] [Abstract][Full Text] [Related]
20. Intravenous immunoglobulin therapy for patients with idiopathic cardiomyopathy and endomyocardial biopsy-proven high PVB19 viral load.
Dennert R; Velthuis S; Schalla S; Eurlings L; van Suylen RJ; van Paassen P; Tervaert JW; Wolffs P; Goossens VJ; Bruggeman C; Waltenberger J; Crijns HJ; Heymans S
Antivir Ther; 2010; 15(2):193-201. PubMed ID: 20386074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
